The investment follows Harlan's consolidation of its Füllinsdorf operations into the Itingen site. Harlan has also launched a recruitment effort to expand its Histology expertise, along with new processing equipment.
“This is an exciting development which we believe will offer many benefits to our customers,” said Hans Thunem, chief executive officer of Harlan Laboratories. “We indicated last year that our commitment to our operations in Switzerland was strong but being tested by lack of profitability. With the results delivered by our employees over the last 12 months, it is rewarding to now be able to make new investments in our Swiss operations.”